Literature DB >> 19369479

Expression of interleukin-5 and tumor necrosis factor alpha in cervical carcinoma.

Dae Woo Lee1, Young Tae Kim, Sang Wun Kim, SungHoon Kim, Jae Hoon Kim, Myung Hwa Kang, Jeong Hye Hwang, Jong baeck Lim.   

Abstract

Interleukin-5 (IL-5) levels were significantly higher in vaginal washing fluids from patients with cervical carcinoma than in those from patients with carcinoma in situ and controls. Tumor necrosis factor alpha levels did not differ among the three groups. Detection of IL-5 in cervical secretions may be a useful marker for evaluating aggressive local immune response in cervical carcinoma.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19369479      PMCID： PMC2691046          DOI： 10.1128/CVI.00262-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  14 in total

1.  Human TH1 and TH2 subsets: doubt no more.

Authors:  S Romagnani
Journal:  Immunol Today       Date:  1991-08

2.  Tumor-associated eosinophilic infiltrate of cervical cancer is indicative for a less effective immune response.

Authors:  W J van Driel; P C Hogendoorn; F W Jansen; A H Zwinderman; J B Trimbos; G J Fleuren
Journal:  Hum Pathol       Date:  1996-09       Impact factor: 3.466

3.  Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.

Authors:  M Clerici; M Merola; E Ferrario; D Trabattoni; M L Villa; B Stefanon; D J Venzon; G M Shearer; G De Palo; E Clerici
Journal:  J Natl Cancer Inst       Date:  1997-02-05       Impact factor: 13.506

4.  Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions.

Authors:  Khadijeh K Azar; Mayuko Tani; Hideyo Yasuda; Akemi Sakai; Masaki Inoue; Toshiyuki Sasagawa
Journal:  Hum Pathol       Date:  2004-11       Impact factor: 3.466

5.  Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia.

Authors:  M Y Tjiong; N van der Vange; J S ter Schegget; M P Burger; F W ten Kate; T A Out
Journal:  Cytokine       Date:  2001-06-21       Impact factor: 3.861

6.  Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study.

Authors:  N Ylitalo; P Sørensen; A M Josefsson; P K Magnusson; P K Andersen; J Pontén; H O Adami; U B Gyllensten; M Melbye
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

7.  Th1 cytokine patterns in cervical human papillomavirus infection.

Authors:  M Scott; D P Stites; A B Moscicki
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

8.  Presence of an eosinophilic infiltrate in cervical squamous carcinoma results from a type 2 immune response.

Authors:  W J van Driel; P Kievit-Tyson; L C van den Broek; A H Zwinderman; B J Trimbos; G J Fleuren
Journal:  Gynecol Oncol       Date:  1999-08       Impact factor: 5.482

9.  The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix.

Authors:  C A Sun; H C Lai; C C Chang; S Neih; C P Yu; T Y Chu
Journal:  Gynecol Oncol       Date:  2001-10       Impact factor: 5.482

10.  Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression.

Authors:  M E Rothenberg; A D Luster; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205
View more
  2 in total

1.  Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.

Authors:  Geert Zegels; Geert Aa Van Raemdonck; Wiebren Aa Tjalma; Xaveer Wm Van Ostade
Journal:  Proteome Sci       Date:  2010-12-08       Impact factor: 2.480

2.  The inhibitory effect of a novel polypeptide fraction from Arca subcrenata on cancer-related inflammation in human cervical cancer HeLa cells.

Authors:  Yu Wu; Xianjing Hu; Liyan Song; Jianhua Zhu; Rongmin Yu
Journal:  ScientificWorldJournal       Date:  2014-02-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.